Bardwell A Jane, Lagunes Leonila, Zebarjedi Ronak, Bardwell Lee
From the Department of Developmental and Cell Biology, Center for Complex Biological Systems, University of California, Irvine, California 92697.
From the Department of Developmental and Cell Biology, Center for Complex Biological Systems, University of California, Irvine, California 92697
J Biol Chem. 2017 May 26;292(21):8750-8761. doi: 10.1074/jbc.M116.767087. Epub 2017 Apr 10.
Mitogen-activated protein kinase (MAPK) scaffold proteins, such as IQ motif containing GTPase activating protein 1 (IQGAP1), are promising targets for novel therapies against cancer and other diseases. Such approaches require accurate information about which domains on the scaffold protein bind to the kinases in the MAPK cascade. Results from previous studies have suggested that the WW domain of IQGAP1 binds to the cancer-associated MAPKs ERK1 and ERK2, and that this domain might thus offer a new tool to selectively inhibit MAPK activation in cancer cells. The goal of this work was therefore to critically evaluate which IQGAP1 domains bind to ERK1/2. Here, using quantitative binding assays, we show that the IQ domain of IQGAP1 is both necessary and sufficient for binding to ERK1 and ERK2, as well as to the MAPK kinases MEK1 and MEK2. Furthermore, we show that the WW domain is not required for ERK-IQGAP1 binding, and contributes little or no binding energy to this interaction, challenging previous models of how WW-based peptides might inhibit tumorigenesis. Finally, we show that the ERK2-IQGAP1 interaction does not require ERK2 phosphorylation or catalytic activity and does not involve known docking recruitment sites on ERK2, and we obtain an estimate of the dissociation constant ( ) for this interaction of 8 μm These results prompt a re-evaluation of published findings and a refined model of IQGAP scaffolding.
丝裂原活化蛋白激酶(MAPK)支架蛋白,如含IQ模体的GTP酶激活蛋白1(IQGAP1),是针对癌症和其他疾病的新型疗法的有前景的靶点。此类方法需要关于支架蛋白上哪些结构域与MAPK级联反应中的激酶结合的准确信息。先前研究的结果表明,IQGAP1的WW结构域与癌症相关的MAPK ERK1和ERK2结合,因此该结构域可能提供一种新工具来选择性抑制癌细胞中的MAPK激活。因此,这项工作的目标是严格评估哪些IQGAP1结构域与ERK1/2结合。在这里,我们使用定量结合测定法表明,IQGAP1的IQ结构域对于与ERK1和ERK2以及MAPK激酶MEK1和MEK2结合既是必需的也是充分的。此外,我们表明ERK-IQGAP1结合不需要WW结构域,并且对这种相互作用贡献很少或没有结合能,这对先前基于WW的肽如何抑制肿瘤发生的模型提出了挑战。最后,我们表明ERK2-IQGAP1相互作用不需要ERK2磷酸化或催化活性,并且不涉及ERK2上已知的对接募集位点,并且我们获得了这种相互作用的解离常数()的估计值为8μm。这些结果促使对已发表的研究结果进行重新评估,并完善IQGAP支架模型。